Sapropterin Dihydrochloride

CHEMBL1201775 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
314.2 g/mol
LogP
Phase
4

Sapropterin dihydrochloride is the dihydrochloride salt form of sapropterin, a synthetic tetrahydrobiopterin used to treat BH4-responsive phenylketonuria and hyperphenylalaninemia. See sapropterin for complete pharmacological details.

Peso molecular

314,1700 g/mol

TPSA

132,00 Ų

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H](O)[C@H](O)[C@H]1CNc2[nH]c(N)nc(=O)c2N1.Cl.Cl

InChI

InChI=1S/C9H15N5O3.2ClH/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7;;/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17);2*1H/t3-,4+,6-;;/m0../s1

Molecular Formula

C9H17Cl2N5O3

HBD / HBA

8 / 6

Enlaces Rotables

2

Átomos Pesados

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Sapropterin dihydrochloride is the dihydrochloride salt form of sapropterin, a synthetic tetrahydrobiopterin used to treat BH4-responsive phenylketonuria and hyperphenylalaninemia. See sapropterin for complete pharmacological details.

Yes, Sapropterin Dihydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201775. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135409471. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.